Annette E. Bowyer
Sheffield, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
A new, rapid, chemiluminescence enzyme assay for the detection of heparin-induced thrombocytopenia: a comparison between functional and immune heparin-induced thrombocytopenia assays.
Journal: Research and practice in thrombosis and haemostasis
Published: December 24, 2025
Is Incubation for 30 Minutes at 56°C Sufficient to Fully Inactivate Efanesoctocog Alfa?
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: July 23, 2025
Reporting haemostasis assays in IU/dL-A recommendation for harmonisation from the British Society for Haematology Haemostasis and Thrombosis Task Force, UK NEQAS for Blood Coagulation and the UK Haemophilia Centres Doctors Organisation.
Journal: British journal of haematology
Published: June 18, 2025
The Laboratory Monitoring of Altuvoct (Efanesoctocog Alfa): Recommendations From the Laboratory Working Party of the United Kingdom Haemophilia Centres Doctor's Organisation.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: June 16, 2025
Monitoring ultralong half-life recombinant factor VIII: a product-specific calibrator is urgently needed to enable accurate measurement in all patients.
Journal: Journal of thrombosis and haemostasis : JTH
Published: January 07, 2025
UKHCDO gene therapy taskforce: Guidance for implementation of haemophilia gene therapy into routine clinical practice for adults.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: July 20, 2024
Evaluation of one-stage and chromogenic assays for the laboratory measurement of factor VIII activity following valoctocogene roxaparvovec infusion.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: March 15, 2024
Guideline for laboratory diagnosis and monitoring of von Willebrand disease: A joint guideline from the United Kingdom Haemophilia Centre Doctors' Organisation and the British Society for Haematology.
Journal: British journal of haematology
Published: November 28, 2023
Clinical Implications of Discrepancy between One-Stage Clotting and Chromogenic Factor IX Activity in Hemophilia B.
Journal: Thrombosis and haemostasis
Published: July 26, 2023
A next generation FVIII mimetic bispecific antibody, Mim8, the impact on non-factor VIII related haemostasis assays.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: July 06, 2023
A foundation to better care: Target product profile for haemophilia and Von Willebrand disease point-of-care diagnostics in low-resource settings.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: May 16, 2023
Agreement between one stage and chromogenic assays in samples from patients receiving recombinant porcine FVIII (Obizur, Susoctocog-alfa).
Journal: International journal of laboratory hematology
Published: March 07, 2023
Last Updated: 09/26/2026